Navigation Links
Gene Network Sciences Awarded Patent Covering REFS(TM) Platform
Date:5/4/2009

CAMBRIDGE, Mass., May 4 /PRNewswire/ -- Gene Network Sciences, Inc. (GNS) today announced that it has been awarded U.S. Patent No. 7,512,497, entitled "Systems and Methods for Inferring Biological Networks." The patent covers GNS's core model learning and simulation platform, REFS(TM) (Reverse Engineering and Forward Simulation).

GNS has deployed the REFS(TM) platform in several collaborations with pharmaceutical and biotechnology companies and academic and clinical institutions in diseases areas such as oncology, rheumatoid arthritis, cardiovascular and metabolic disease, and Alzheimer's disease. The REFS(TM) platform, which is run on supercomputers, enables the rapid extraction of actionable, patient-specific knowledge directly from experimental and clinical data.

"We have now extended our patent portfolio beyond our previous issued patents covering an ultra-efficient language to model known biology and the simulation of known pathways, to the fully data-driven inference and simulation of novel biology," said Tom Neyarapally, Senior Vice President of Corporate Development for GNS. "GNS now has broad intellectual property coverage across our modeling and simulation activities."

GNS has several other pending patent applications addressing the REFS(TM) platform and its use in areas of application in biological systems and areas outside of biology such as quantitative finance, online advertising, and natural resource exploration, as well as applications covering drug targets, biomarkers, and diagnostic markers discovered using the REFS(TM) platform.

About Gene Network Sciences

Gene Network Sciences (http://www.gnsbiotech.com/) is a leader in biosimulation with its ability to derive molecular mechanisms of drugs and diseases directly from molecular profiling and clinical data. Based in Cambridge, Massachusetts, and Ithaca, New York, GNS uses its REFS(TM) technology in pharmaceutical and clinical settings to rapidly turn combinations of genetic, genomic, and clinical measurements into models of disease progression and drug response. These models are then simulated to discover both new targets for drug intervention and genetic markers of drug response that allow patients who will respond to a given drug treatment to be matched to a particular clinical trial. By discovering how and why specific sets of genes and drug candidates impact human biology, GNS technology enables the rapid development of breakthrough drug and diagnostic products.


'/>"/>
SOURCE Gene Network Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Healthy Living Network Announces Launch of New Blood Sugar Web Site
2. Blue Cross Blue Shield of Michigan and Blue Care Network Launch Web Sites to Help Chrysler Members Easily Find Information on Their Health Care
3. Technologically Advanced Digital Handheld Device Positions Network Global Logistics as Technology Leader in Last Mile Delivery Solutions
4. Healthy Living Network Announces Launch of New Supplement Information Web Site
5. Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB
6. Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency
7. Insurers Administrative Corporation Joins the Availity Network
8. Anthem Blue Cross and Blue Shield and Middlesex Hospital Renew Network Agreement
9. Health Caring - A Network of Strength
10. Family Healthcare Network Selects InteGreat EHR for Deployment of Browser-Based EHR
11. Agito Networks Named to the First Annual InformationWeek Startup 50 Listing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Sherly ... for a series of therapeutic sessions to help Los Angeles-area actors cope with ... their lives. The series, known as “Mindfulness for Actors and Artists,” has been ...
(Date:2/10/2016)... ... 2016 , ... LaserShip, a regional parcel carrier that services the eastern U.S., ... last Friday in order to aid in the Flint water crisis. In 2014, LaserShip ... located in Clio, only 15 miles away from Flint. , “We have deep roots ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... together to expand dental health services to the developmentally disabled in the Coachella ... Dental’s operations to a new facility at 71-949 Highway 111, Suite 100-B, in ...
(Date:2/10/2016)... ... 2016 , ... As part of its ongoing series of aquatic therapy related ... features a dynamic expert and thoughtful presentation to give attendees a better sense of ... events are free to attend, but registration is required. , Rehabilitation of ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... American Academy of Emergency Medicine , an emergency medicine professional association, ... practice management services . , The American Academy of Emergency Medicine, or AAEM, ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Urologix, the market leader for in-office minimally invasive ... (BPH), announces new private ownership and is operating as ... industry veteran of more than 20 years, has been ... Plymouth, Minn. The company,s two ... RF Therapy, will continue to be broadly available and ...
(Date:2/10/2016)... , February 10, 2016 A ... which will be held at Victoria Park Plaza in ... an informative seminar on technology and future advances for late ... led by Lorna Graham , associate director of project ... to keep up with new regulations and standards in late ...
(Date:2/10/2016)... , Feb. 10, 2016  Visage Imaging ... Medicus Ltd. (ASX: PME), has announced that the American ... Florida (UF) have selected the Visage 7 Enterprise ... of the Emergent/Critical Care Imaging SIMulation (SIM). SIM ... Diagnostic Imaging Program (WIDI), a multi-faceted and fully-integrated ...
Breaking Medicine Technology: